These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 1989663)

  • 21. Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.
    Visser GW; Gerretsen M; Herscheid JD; Snow GB; van Dongen G
    J Nucl Med; 1993 Nov; 34(11):1953-63. PubMed ID: 8229241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model.
    Blumenthal RD; Sharkey RM; Kashi R; Goldenberg DM
    Int J Cancer; 1989 Aug; 44(2):292-300. PubMed ID: 2759735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative tumor localization of whole immunoglobulin G anticarcinoembryonic antigen monoclonal antibodies IMMU-4 and IMMU-4 F(ab')2 in colorectal cancer patients.
    Murray JL; Rosenblum MG; Zhang HZ; Podoloff DA; Kasi LP; Curley SA; Chan JC; Roh M; Hohn DC; Brewer H
    Cancer; 1994 Feb; 73(3 Suppl):850-7. PubMed ID: 8306270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
    Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model.
    Peräalä-Heape M; Vihko P; Vihko R
    Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The localisation of radiolabelled murine monoclonal antibody 81C6 and its Fab fragment in human glioma xenografts in athymic mice.
    Colapinto EV; Lee YS; Humphrey PA; Zalutsky MR; Friedman HS; Bullard DE; Bigner DD
    Br J Neurosurg; 1988; 2(2):179-91. PubMed ID: 3267302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
    Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J
    Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposes.
    van Schaijk FG; Boerman OC; Soede AC; McBride WJ; Goldenberg DM; Corstens FH; Oosterwijk E
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1089-95. PubMed ID: 15902440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of circulatory clearance of tumour-localising IgG and F(ab')2 for potential therapy studied in a CEA-producing xenograft model.
    Harwood PJ; Pedley RB; Boden J; Rogers GT
    Tumour Biol; 1987; 8(1):19-25. PubMed ID: 3602844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of radioimmunotherapy using murine monoclonal antibody KIS1 on esophageal squamous cell carcinoma-bearing nude mice.
    Fujii T; Yamana H; Toh Y; Toh U; Fujita H; Shirouzu K; Morimatsu M
    Surg Today; 1997; 27(11):1026-34. PubMed ID: 9413055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts.
    Colapinto EV; Humphrey PA; Zalutsky MR; Groothuis DR; Friedman HS; de Tribolet N; Carrel S; Bigner DD
    Cancer Res; 1988 Oct; 48(20):5701-7. PubMed ID: 3167830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
    Sharkey RM; Motta-Hennessy C; Pawlyk D; Siegel JA; Goldenberg DM
    Cancer Res; 1990 Apr; 50(8):2330-6. PubMed ID: 2180566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
    Casey JL; King DJ; Chaplin LC; Haines AM; Pedley RB; Mountain A; Yarranton GT; Begent RH
    Br J Cancer; 1996 Nov; 74(9):1397-405. PubMed ID: 8912535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The strength of small: improved targeting of insulin-like growth factor-1 receptor (IGF-1R) with F(ab')₂-R1507 fragments in Ewing sarcomas.
    Fleuren ED; Versleijen-Jonkers YM; Heskamp S; Roeffen MH; Bouwman WH; Molkenboer-Kuenen JD; van Laarhoven HW; Oyen WJ; Boerman OC; van der Graaf WT
    Eur J Cancer; 2013 Sep; 49(13):2851-8. PubMed ID: 23664098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tumour mass and circulating antigen on the biodistribution of 111In-labelled F(ab')2 fragments of human prostatic acid phosphatase monoclonal antibody in nude mice bearing PC-82 human prostatic tumour xenografts.
    Perälä-Heape M; Vihko P; Laine A; Heikkilä J; Vihko R
    Eur J Nucl Med; 1991; 18(5):339-45. PubMed ID: 1936042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.
    de Bree R; Roos JC; Plaizier MA; Quak JJ; van Kamp GJ; den Hollander W; Snow GB; van Dongen GA
    Br J Cancer; 1997; 75(7):1049-60. PubMed ID: 9083342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
    Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
    Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.
    Bruland O; Fodstad O; Skretting A; Pihl A
    Br J Cancer; 1987 Jul; 56(1):21-5. PubMed ID: 3476143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.